Investor Skip Fleshman of Asset Management Ventures told his audience that biotech exits have been “white hot” in the past year and a half. “With growing resources and improvements in science and technology, we will start the next great gene technology in someone’s garage,“ said Butte. Atul Butte, founder of two StartX Med companies and distinguished educator at the Stanford School of Medicine, delivered a rallying talk. Veteran investor Brook Byers of VC firm Kleiner, Perkins, Caufield, and Byers won the hearts of his audience by asserting, “If you can build a medical company, you can do anything. Just as there are legacy companies with entrenched attitudes, the same for entrepreneurs,” he said. “The opportunities for emerging innovators are the best I’ve seen in my career, but it is going to take a really major shift. Paul Yock, the founder and director of the Stanford Biodesign program, delivered the morning keynote and charged up the audience. Throughout the day, the energy on stage and in the standing-room only crowd was optimistic. The conversations included large group addresses as well as 1:1 scheduled sessions with seasoned industry professionals and startup founders. 20 hospitals piloting StartX Med technologiesĭozens of speakers, mentors, and panelists collectively offered a “pulse check” on their respective industries and roles.Lee, who is also co-founder of StartX Med biotech company Stem Cell Theranostics, offered updates about StartX Med, which he helped found as a community-based, six-month program for Stanford-affiliated entrepreneurs: We are happy to reach a point where we can now begin to share our educational resources with the community,” said Andrew Lee, co-founder of StartX Med. “StartX Med Day is an intense injection of practical knowledge sharing about medical and biotech entrepreneurship. Held at the new StartX headquarters next to Stanford University, the gathering was the first of its kind for the nonprofit med/biotech accelerator program, which launched in May 2012 and normally only supports StartX Med entrepreneurs. The one day event drew close to 150 medical and biotechnology influencers and 45 startups from the San Francisco Bay Area to share business, research, and investment insights. StartX Med, the division of StartX dedicated to medical and biotechnology entrepreneurs, launched its first ever StartX Med Day on Thursday.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |